当前位置: X-MOL 学术Alzheimers Dement. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study
Alzheimer's & Dementia ( IF 14.0 ) Pub Date : 2022-06-17 , DOI: 10.1002/alz.12696
Daniele Altomare 1, 2 , Lyduine Collij 3 , Camilla Caprioglio 1, 2 , Philip Scheltens 4 , Bart N M van Berckel 3 , Isadora Lopes Alves 3 , Johannes Berkhof 5 , Yvonne de Gier 3 , Valentina Garibotto 6, 7 , Christian Moro 1, 2 , Léa Poitrine 1, 2 , Julien Delrieu 8, 9 , Pierre Payoux 10, 11 , Laure Saint-Aubert 10, 12 , José Luis Molinuevo 13, 14 , Oriol Grau-Rivera 13, 15, 16 , Juan-Domingo Gispert 13, 15, 17 , Carolina Minguillón 13, 15, 16 , Karine Fauria 13, 16 , Marta Felez Sanchez 13 , Andreea Rădoi 13 , Alexander Drzezga 18, 19, 20 , Frank Jessen 21 , Claus Escher 21 , Philip Zeyen 21 , Agneta Nordberg 22, 23 , Irina Savitcheva 24 , Vesna Jelic 25 , Zuzana Walker 26, 27 , Ho-Yun Lee 27 , Lean Lee 26 , Jean-François Demonet 28 , Sonia Plaza Wuthrich 28 , Rossella Gismondi 29 , Gill Farrar 30 , Frederik Barkhof 3, 31 , Andrew W Stephens 29 , Giovanni B Frisoni 1, 2 ,
Affiliation  

AMYPAD Diagnostic and Patient Management Study (DPMS) aims to investigate the clinical utility and cost-effectiveness of amyloid-PET in Europe. Here we present participants’ baseline features and discuss the representativeness of the cohort.

中文翻译:

接受淀粉样蛋白 PET 的欧洲记忆诊所队列的描述:AMYPAD 诊断和患者管理研究

AMYPAD 诊断和患者管理研究 (DPMS) 旨在调查欧洲淀粉样蛋白 PET 的临床效用和成本效益。在这里,我们介绍参与者的基线特征并讨论队列的代表性。
更新日期:2022-06-17
down
wechat
bug